In a significant stride toward advancing equitable cancer care and disseminating cutting-edge biomedical research, the National Comprehensive Cancer Network® (NCCN®) has announced a series of prestigious recognitions for its staff and initiatives, underscoring the organization’s unwavering commitment to transforming oncology practice and patient education worldwide. Headquartered in Plymouth Meeting, PA, NCCN continues to establish itself as a beacon of scientific rigor and health equity, catalyzing innovations in policy, research, clinical guidelines, and patient resources, all converging to elevate the standard of cancer treatment.
NCCN’s Vice President of Policy and Advocacy, Dr. Alyssa Schatz, DrPH, MSW, has garnered distinguished accolades for her leadership in policy development, equity, and advocacy. Honored by the National Minority Quality Forum (NMQF) with the Booker T. Washington Award, Dr. Schatz’s contributions epitomize the network’s systemic approach to redressing disparities in cancer care. Her collaborative efforts with the Alliance for Cancer Care Equity—comprising partners such as NMQF and the American Cancer Society Cancer Action Network—focus on advancing actionable frameworks to enhance health equity. Central to these efforts is the creation and implementation of the Health Equity Report Card (HERC), a pioneering tool designed to measure and incentivize equitable cancer care practices through comprehensive data transparency and patient-centered metrics.
The HERC embodies a sophisticated approach to health systems analysis, leveraging empirical data to inform clinical decision-making and organizational policy. A recent article published in the Journal of Oncology Navigation & Survivorship, co-authored by senior equity program manager Taneal D. Carter, DHSc, MPA, MS, alongside Dr. Schatz and researchers from Virginia Commonwealth University’s Massey Comprehensive Cancer Center, presents initial feasibility outcomes of HERC application in community-based oncology settings. Their findings elucidate the necessity for sustained stakeholder engagement and iterative tool refinement, emphasizing data-driven strategies as indispensable for catalyzing equitable cancer care transformations across diverse clinical environments.
At the forefront of biochemical research recognition, Dr. Faviolla Baez-Cruz, PhD, an associate scientist and medical writer within NCCN’s clinical information department, has been awarded one of the 2026 Journal of Biological Chemistry honors by the American Society for Biochemistry and Molecular Biology (ASBMB). Dr. Baez-Cruz’s acclaimed publication, “Dynamics of β-Cardiac Myosin Between the Super-Relaxed and Disordered-Relaxed States,” dissects the molecular conformational states of β-cardiac myosin—an intricate motor protein critical to cardiac muscle contraction. The research, conducted in collaboration with co-author Robert C. Cail prior to her tenure at NCCN, elucidates the biochemical underpinnings responsible for myosin’s role in both physiological function and the pathogenesis of cardiomyopathies, providing foundational insights into cardiac dysfunction at the molecular level.
Inside NCCN, Dr. Baez-Cruz plays an integral role in the continuous refinement and global adaptation of the NCCN Clinical Practice Guidelines in Oncology, universally recognized as the authoritative, evidence-based consensus protocols delineating optimal cancer treatment pathways. Her scientific expertise aids in the digitization and patient-centric transformation of these guidelines, notably through contributions to the NCCN Guidelines Navigator™, an innovative digital platform that enhances clinician access to up-to-date guideline recommendations in real time, fostering precision oncology and personalized care.
Equally transformative are NCCN’s efforts to empower patients and caregivers through accessible, evidence-based educational materials. The NCCN Guidelines for Patients® series recently attained a prestigious Gold Hermes Creative Award in recognition of the Bone Cancer patient guideline publication. This honor, bestowed by the Association of Marketing and Communication Professionals, underscores the NCCN’s commitment to translating complex oncological knowledge into clear, visually engaging, and culturally sensitive resources that facilitate informed patient decision-making. With over 70 comprehensive titles covering an extensive range of cancer types, prevention strategies, and supportive care modalities, these guidelines bridge the informational gap between oncology specialists and the individuals navigating cancer treatment.
Significantly, NCCN ensures these vital patient education resources remain perpetually accessible by offering them free of charge, supported by the NCCN Foundation®. This commitment extends to annual multilingual updates, as exemplified by the latest revision of the Bone Cancer guideline in March 2026, which integrates the most current clinical evidence and patient feedback to maintain relevance and usability. Moreover, the Liver Cancer patient guideline has earned distinction as a finalist for the 2026 ClearMark Award, which acknowledges excellence in plain language communication, further validating NCCN’s leadership in patient-centric health literacy.
NCCN’s holistic approach bridges clinical research, policy, and patient education, facilitating a continuum of cancer care improvements rooted in equity and scientific excellence. By championing tools like HERC, recognizing biochemical research breakthroughs, and delivering authoritative, accessible guidelines, NCCN exemplifies a multidimensional strategy that aligns clinical practice with social justice imperatives. These achievements underscore the vital importance of collaborative, data-informed, and compassionate cancer care—an approach that promises not only to optimize outcomes but also to transform healthcare landscapes.
The organization’s leadership, including CEO Dr. Crystal S. Denlinger, MD, emphasizes the profound impact of these recognitions as both validation and inspiration to continue advancing cancer care innovation. Through the tireless dedication of its researchers, clinicians, and policy advocates, NCCN remains at the vanguard of oncology, steering global efforts towards more effective, equitable, and patient-centered cancer management.
Ultimately, NCCN’s achievements spotlight the critical intersection of scientific discovery, equitable policy development, and patient empowerment. The network’s ongoing collaborations, research achievements, and educational initiatives forge new paradigms in oncology, exemplifying how integrated, multidisciplinary efforts can elevate patient outcomes and advance health equity on a global scale.
Subject of Research: Cancer care equity, biochemical mechanisms of β-cardiac myosin, development of clinical practice guidelines, and patient education in oncology.
Article Title: Empowering Cancer Care through Policy Advocacy, Biochemical Innovation, and Patient-Centered Education: Recognition of NCCN’s Multifaceted Contributions
News Publication Date: April 29, 2026
Web References:
- NCCN Health Equity Report Card (HERC): https://www.nccn.org/docs/default-source/oncology-policy-program/herc-healthcare-full.pdf
- Journal of Oncology Navigation & Survivorship report: https://www.jons-online.com/issues/2026/march-2026-vol-17-no-2/empowering-community-based-practices-to-deliver-equitable-cancer-care
- ASBMB Journal of Biological Chemistry Awardees: https://www.asbmb.org/asbmb-today/people/021826/asbmb-announces-2026-jbc-tabor-awardees
- NCCN Clinical Practice Guidelines: https://www.nccn.org/guidelines/guidelines-process/about-nccn-clinical-practice-guidelines
- NCCN Guidelines Navigator: https://www.nccn.org/guidelines/nccn-guidelines-navigator
- NCCN Guidelines for Patients: https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients
References:
- Carter, T. D., Schatz, A., et al. (2026). Empowering Community-Based Practices to Deliver Equitable Cancer Care. Journal of Oncology Navigation & Survivorship, Vol 17(2).
- Baez-Cruz, F., Cail, R. C., et al. (2025). Dynamics of β-Cardiac Myosin Between the Super-Relaxed and Disordered-Relaxed States. Journal of Biological Chemistry.
Image Credits: Credit: NCCN
Keywords: Cancer care equity, oncology guidelines, β-cardiac myosin, health policy, patient education, health disparities, clinical practice guidelines, biochemical research, NCCN, health communication, cancer advocacy, biomedical innovation
